
Bioorganic and Medicinal Chemistry Letters p. 1787 - 1790 (1998)
Update date:2022-08-03
Topics:
Chambers
Koch
Biggers
Ramchandani
Structural modification of 1 led to a series of 2-(4-hydroxy-7- chromanyl)benzoic acid LTB4 antagonists exemplified by 2 and 3. The use of an organostannane biaryl coupling, a non stereoselective reduction and a chromatographic resolution limited the utility of this synthetic route. To address these issues, a new synthetic route was developed utilizing a palladium catalyzed coupling of aryl oxazolines in tandem with a stereospecific enone reduction as key synthetic steps. Resolution was achieved by fractional crystallization of a (S)-(-)-α-methylbenzylamine salt.
View MoreJiangxi Runhao Pharmaceutical Stock Co.,ltd.
Contact:86-791-8861 9931
Address:Industrial Area of Shuibian town,Xiajiang county,Ji'an city,Jiangxi Province.
Yingkou Sanzheng Organic Chemical Co. Ltd.
Contact:+86-417-3638818
Address:25 Gengxinli Village, Daqing Road, Yingkou, Liaoning, China
Contact:+86-22-26358246
Address:601-4-20, Fujiayuan, Tiantai Road, Hebei District, Tianjin, China
Xi'an Galaxy Chemicals CO., Ltd
Contact:86-29-89380370
Address:No.8, Gaoxin three road, Xi'an city.
Jiangsu Fengshan Group Co., Ltd.
Contact:86-25-86558671
Address:1903,Central International Mansion 105-6 North Zhongshan Road, Nanjing, China
Doi:10.1016/j.bmcl.2013.07.023
(2013)Doi:10.1021/ja962990n
(1997)Doi:10.1002/anie.201302815
(2013)Doi:10.1016/0031-9422(92)83296-B
(1992)Doi:10.1038/sj.bjp.0704611
(1957)Doi:10.3390/molecules18055697
(2013)